Navigation Links
ARIUS announces second quarter fiscal 2008 financial results
Date:7/11/2008

nts, short-term investments and net working capital of $5,635,365, $6,825,190 and $9,088,712, respectively. The Company currently believes that it has adequate financial resources to continue into the fourth quarter of fiscal 2008 based on planned research and development expenditures and operating costs.

About ARIUS

ARIUS is a biotechnology company discovering and developing the next wave of antibody therapeutics. Established in 1999, ARIUS has built a proprietary technology platform, FunctionFIRST(TM), that rapidly identifies and selects antibodies based on their functional ability to affect disease. This antibody generation engine has enabled ARIUS to assemble a portfolio of more than 500 antibody candidates. In addition to the antibodies it is developing in-house, ARIUS has ongoing partnerships with key biotechnology and drug development companies. ARIUS is listed on the TSX under the symbol "ARI". For further information, visit http://www.ariusmabs.com

Financial Information to Follow:

ARIUS RESEARCH INC.

(A DEVELOPMENT STAGE COMPANY)

INTERIM BALANCE SHEETS

(Unaudited)

-------------------------------------------------------------------------

May 31, November 30,

2008 2007

$ $

-------------------------------------------------------------------------

Assets

Current assets:

Cash and cash equivalents 8,543,124 5,635,365

Short-term investments - 6,825,190

Receivables 185,672 230,126

Refundable tax credits 600,000 400,000

Prepaid expenses
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. ARIUS presents new findings for anti-cancer antibody programs at AACR
2. ARIUS announces first quarter fiscal 2008 financial results
3. ARIUS 2008 Annual and Special Meeting of Shareholders
4. ARIUS recognized for entrepreneurial excellence
5. ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting
6. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
7. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
8. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
9. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
10. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
11. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014 Rancho BioSciences ... integration of Omicsoft’s Array Suite with tranSMART . ... be able to send data in tranSMART to Array ... all versions of tranSMART including the new 1.2 release. ... visualization and storage for the analysis of high dimensional ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 “Rapid ... automation across the U.S., increasing unemployment, depressing American ... It is a Catch 22—we need automated ... this means fewer jobs,” says economist and corporate ... Pollina Corporate Top 10 Pro-Business States for 2014, ...
(Date:7/31/2014)... The Kidney Cancer Association (KCA) has established a ... Kidney Cancer News. , Bill Bro, KCA CEO, says, ... by an international news organization. When we began using iReport ... This month’s program highlights news of an enzyme that is ... recent study. Kidney Cancer News also presents a report on ...
(Date:7/30/2014)... July 30, 2014 Regulus Therapeutics Inc ... leading the discovery and development of innovative medicines targeting ... and highlights for the quarter ended June 30, 2014 ... markets close. Regulus will host a ... at 5:00 pm Eastern Daylight Time to discuss its ...
Breaking Biology Technology:Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 2Rancho BioSciences, in Partnership with Omicsoft, have Integrated Array Suite with tranSMART 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 2ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 3ITRA Global Affiliate’s Pollina Corporate Top 10 Pro-Business States Minimize the Impact of Automation on Middle Class and Unemployment 4Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2014 Financial Results Webcast and Conference Call 3
... , MENLO PARK, Calif., Sept. 21 ForteBio(R), Inc., ... biotherapeutic and pharmaceutical products, announced today that Joseph D. Keegan, Ph.D., ... Global Life Sciences Conference on Wednesday, September 23, 2009. His presentation ... Grand Hyatt Hotel in New York City. , , ...
... NEW YORK, Sept. 21 Emissary Capital ... Inc. (OTC Bulletin Board: SNBP) with a Buy rating ... known domestically as Dong Ying Pharmaceutical Co. Ltd., is ... the R&D, manufacture and distribution of biopharmaceutical products. ...
... , SOUTH BEND, Ind., Sept. 21 ... program offering feedback directly to patients regarding their imaging tests within ... noted that in many cases, patients will actually get their test ... results program include diagnostic mammograms, general X-rays and bone density tests, ...
Cached Biology Technology:Emissary Capital Group Initiates Coverage on Sinobiopharma 2XRC Medical Imaging Announces Rapid Test Results 2
(Date:7/31/2014)... A hidden hazard lurks beneath many of the ... , The hazard is corrosion in parts of ... failures, leaks and contamination of groundwater, a source ... in nine states have reported many rapidly corroding ... These incidents are generally associated with use of ...
(Date:7/31/2014)... Neb., July 31, 2014 -- Do people make a ... mothers raise them that way? Is it a matter ... Nebraska-Lincoln and a colleague from Rice University say that ... some people lean left while others lean right. , ... and deep-seated psychology are at the core of political ...
(Date:7/31/2014)... conflagration known as the Rim Fire was in full ... trees, when it entered the backcountry of Yosemite National ... But inside the park, the battle began to turn, ... and drought can combine to fuel large, severe fires. ... eventually encountered lands where fire had been used as ...
Breaking Biology News(10 mins):NIST corrosion lab tests suggest need for underground gas tank retrofits 2Scientists find growing consensus: Political attitudes derive from body and mind 2The Rim Fire 1 year later: A natural experiment in fire ecology and management 2The Rim Fire 1 year later: A natural experiment in fire ecology and management 3The Rim Fire 1 year later: A natural experiment in fire ecology and management 4The Rim Fire 1 year later: A natural experiment in fire ecology and management 5
... blind cave shrimp, and other oddities suggest a "use ... microbial world, an unusual marine microorganism appears to have ... remarkably reduced set of genes. This metabolic ... very important function: taking nitrogen gas from the atmosphere ...
... common gene variant associated with a form of the irregular ... journal Nature Genetics , being published online, the investigators ... control the heart,s electrical activity appear to increase the risk ... seen in younger individuals with no other form of heart ...
... Jacques Cousteau as the "world,s aquarium," the marine ecosystems ... new fishing methods are depleting the sea,s habitats, creating ... Scripps explorations story "Threatened Gulf" . But, ... UC San Diego will describe during a presentation at ...
Cached Biology News:Genome analysis of marine microbe reveals a metabolic minimalist 2Genome analysis of marine microbe reveals a metabolic minimalist 3Common gene variant may increase risk for a type of cardiac arrhythmia 2Damage to threatened Gulf of California habitats can be reversed 2
Rabbit polyclonal to XTP4 ( Abpromise for all tested applications). entrezGeneID: 84299 SwissProtID: Q9BRT3...
Chicken polyclonal to QPRT ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to Internal sequence amino acids 123-237 of Human QPRT Entrez Gene ID: 23475 ...
...
Antibody Diluent for IHC 125 ml...
Biology Products: